#moderna stock

[akhbarhub]

Stock Market Crash: Moderna’s Stock Plummets Amid Sell-Off #akhbarhub #stockmarketcrash #Moderna #Bonds #Stocks

#akhbarhub #stock market crash #Moderna #bonds #stocks #stocks vs bonds

[hashtag-anthems]

Oh the Moderna side effects are beginning

#hashtag rambles #I had three doses of pfizer but the only bivalent booster in stock was Moderna this time #last time I got boosted it wasn’t too bad honestly #but I can tell I’m not getting out of bed today #but side effects are good! because I have an immune deficiency and side effects means I’m having an immune response #I just gotta suffer today

[creativitytoexplore]

Stocks rise as investors look ahead to key consumer inflation data

Stocks rise as investors look ahead to key consumer inflation data

Stocks rose Wednesday as investors shook off inflation data that came in higher than expected and looked ahead to a key consumer report that will inform the pace of the Federal Reserve’s rate hikes going forward. The Dow Jones Industrial Average gained 169 points, or 0.58%. The S&P 500 rose 0.28%, bolstered by a 10% jump in shares of Moderna, the top gaining stock in the index. The Nasdaq…

View On WordPress

#Breaking News: Markets #business news #Economic events #Investment strategy #Jerome Powell #Markets #Moderna Inc #Prices #Rocket Lab USA Inc #Stock markets #United States

[mostlysignssomeportents]

The public paid for "Moderna's" vaccine, and now we're going to pay again (and again and again)

Moderna is quadrupling the cost of covid vaccines, from $26/dose to $110–130. Moderna CEO Stephane Bancel calls the price hike “consistent with the value” of the mRNA vaccines. Moderna’s manufacturing costs are $2.85/dose, for a 4,460% markup on every dose:

https://arstechnica.com/science/2023/01/moderna-may-match-pfizers-400-price-hike-on-covid-vaccines-report-says/

If you’d like an essay-formatted version of this thread to read or share, here’s a link to it on pluralistic.net, my surveillance-free, ad-free, tracker-free blog:

https://pluralistic.net/2023/01/24/nationalize-moderna/#herd-immunity

Now, obviously the manufacturing costs are only part of the cost of making a vaccine: there’s also all the high-risk capital that goes into doing the basic research. Whenever a pharma company like Moderna hikes its prices, we’re reminded that the rewards are commensurate with these risks.

But the story of the Moderna vaccine isn’t one of a company taking huge gambles with shareholder dollars. It’s the story of the US government giving billions and billions of dollars to a private firm, which will now charge the US government — and the American people — a 4,460% markup on the resulting medicine.

Writing for The American Prospect, Lily Meyersohn reminds us of the Moderna vaccine’s origin story: the NIH spent $1.4B developing the underlying technology and then the US government bought $8b worth of vaccines at $16/dose, giving Moderna a guaranteed 460% margin on each jab:

https://prospect.org/health/2023-01-23-moderna-covid-vaccine-price-hike-bernie-sanders/

Moderna clearly does not feel that the billions it received in public funds came with any obligation to serve the public interest. The company falsified its patent applications, omitting the NIH scientists who co-developed the vaccine, claiming sole ownership:

https://blog.petrieflom.law.harvard.edu/2022/01/06/nih-moderna-mrna-covid-vaccine-patent/

As Meyersohn writes, this omission allows Moderna to block the NIH from licensing the vaccine to foreign manufacturers — including vaccine manufacturers in the global south, home to many powerhouse producers of vaccines:

https://pluralistic.net/2022/08/24/waivers-for-me-not-for-thee/#vaccine-apartheid

Moderna claims to have capitulated to the NIH on the patent question, but it’s a lie — even as they were publicly announcing they would drop their bid to exclude NIH scientists from their patent application, they quietly filed for a continuance that would let them renew their exclusive claim later, when the heat has died down:

https://www.nytimes.com/2021/12/17/us/moderna-patent-nih.html

This maneuver, combined with Astrazeneca reneging on its promise to open its vaccine — a move engineered by Bill Gates — has deprived billions of the world’s poorest people of access to vaccines. Many of these people were previously blocked from accessing AIDS drugs when the Gates Foundation teamed up to block WTO vaccine waivers:

https://pluralistic.net/2021/04/13/public-interest-pharma/#gates-foundation

These immunucompromised, unvaccinated people are at increased risk of contracting covid, and when they do, they are sick for longer, creating more opportunities for viral mutation and new, more virulent variants.

That was where we stood before Moderna announced its 400% vaccine price-hike. Now, millions of Americans will also be blocked from accessing vaccines, opening the door for rampant, repeated infections, more mutations, and more variants. As Alex Lawson of Social Security Works told Meyersohn, at that price, the US will not be able to achieve herd immunity.

What will Moderna do with the billions it reaps through price-gouging? It won’t be research. To date, the company has spent >20% of its covid windfall profits on stock buybacks and dividends, manipulating its stock price, with more to come:

https://www.levernews.com/how-big-pharma-actually-spends-its-massive-profits/

It’s not an outlier. Big Pharma is a machine for commercializing publicly funded research and then laundering the profits with financial engineering. The largest pharma companies each spend more on stock buybacks than research:

https://www.levernews.com/how-big-pharma-actually-spends-its-massive-profits/

Moderna didn’t have a single successful product for its first decade of operation: it is only a going concern because it got billions in free public research and billions more in public commitments to buy its products at a huge markup.

It wasn’t always this way. Until the 1990s, pharma companies that commercialized public research were bound to license terms that required “reasonable pricing.” NIH inventions were subject to non-exclusive licensing terms, ensuring a competitive market.

The NIH could act to stem Moderna’s profiteering. Moderna’s vaccine (like virtually all mRNA vaccines) uses NIH patent 10,960,070 — though Moderna doesn’t license the ‘070 patent. The NIH could use the threat of a patent infringement suit to force Moderna to put pandemic resilience and access to vaccines over financial engineering and executive bonuses.

When it comes to patent enforcement to protect the public interest, the USG has a long history of channeling King Log, letting companies price-gouge with products built on public research.

https://media.nature.com/original/magazine-assets/d41586-021-03535-x/d41586-021-03535-x.pdf

The states are stepping in where the feds have failed to act, spinning up their own pharma production capacity to create a “public option” for medicine — think of California’s move to produce insulin and other meds:

https://prospect.org/health/its-time-for-public-pharma/

Or Massachusetts’s MassBiologics, the “only non-profit, FDA-licensed manufacturer of vaccines” in the USA, which sells its generic tetanus and diptheria vaccines nationwide:

https://www.umassmed.edu/massbiologics/

The US has a long way to go when it comes to using public production to offer competitive discipline to private pharma. Sweden nationalized its pharma in 1970. Cuba got there in 1960, and is a pharma powerhouse:

https://pluralistic.net/2021/11/28/somos-cuba/#omishambles

Meyersohn closes her excellent article with a warning and a promise: though public covid vaccines are a long way away, new vaccines for RSV and even cancer are in the pipeline, and without “substantial intervention,” Moderna will be a “harbinger…of crises of inequitable access to come.”

[Image ID: Moderna headquarters in Cambridge, Mass. On the left side of the entry, a Jacobin with a guillotine gets ready to decapitate an aristocrat. On the right side of the frame, a cigar-chomping, top-hat wearing ogrish figure makes ready to yank a gilded dollar-sign lever while holding an MRNA molecule disdainfully aloft]

#pluralistic #moderna #pharma #big pharma #vaccines #mrna #guillotine watch #public-private pertnerships #sucker at the table #uncle sucker

[reality-detective]

Glenn Beck talks about how Fauci has stock in the company Moderna that owns the mRNA technology patent. You Decide 🤔

#pay attention #educate yourselves #educate yourself #knowledge is power #reeducate yourself #reeducate yourselves #think for yourselves #think about it #think for yourself #do your homework #do some research #do your research #do your own research #ask yourself questions #question everything #you decide #glenn beck

[reddancer1]

Bernie takes on Big Pharma

There is a lot of discussion about how "divided" our nation is and, on many issues, that is absolutely true.

But if you ask most Americans — Democrats, Republicans, independents, progressives, conservatives — they will agree: We are getting ripped off, big time, by the pharmaceutical industry.

The good news — and there is good news — is that scientists have made some amazing and important discoveries that have saved millions of lives during the global COVID pandemic, and others that have the capacity to save and extend the quality of life for people in this country and around the world.

The bad news — and there is plenty of it — is that those advances in science and technology mean nothing if people cannot afford them.

In this country, we pay over 3 times as much as other major countries for brand name prescription drugs, and, in some cases we pay 10 or 20 times more than the people of other countries for the same exact product.

The result of the high cost of prescription drug costs is obvious: One out of four Americans cannot afford to purchase the prescriptions their doctors write and some die as a result.

And if you think the high cost of prescription drugs is just an individual patient or family problem that may not impact you, I am here to tell you that you are mistaken.

This is also a taxpayer issue. The high cost of these medicines drives up the cost of Medicaid, Medicare, and other public health programs as well as private insurance. When people can't afford the medicine they need and get sicker than they should, they end up in emergency rooms or hospitals at great expense to our already bloated and wasteful healthcare system.

So no matter who you are, no matter how healthy or wealthy you are, this is an issue that impacts ALL OF US.

Yet while millions of Americans struggle to pay for the lifesaving medicine they need and all of us pay the price, the drug companies and their executives have never had it so well.

In 2022, Johnson & Johnson made nearly $18 billion in profits, paid its CEO over $27 million in compensation, and spent over $17 billion on stock buybacks and dividends.

That same year, Merck made $14.5 billion in profit, handed out over $7 billion in dividends to their wealthy stockholders, and paid its CEO over $52 million in compensation.

And Bristol Myers Squibb made $6.3 billion in profits last year, while recently spending over $12 billion on stock buybacks and dividends and giving its CEO over $41 million in compensation.

So where do we go from here?

First, let us acknowledge that we have made SOME progress on the issue of lowering the cost of prescription drugs.

As a result of the Inflation Reduction Act, seniors with diabetes are paying no more than $35 a month for the insulin they need; beginning next year, seniors will be paying no more than $2,000 out-of-pocket a year for prescription drugs; and for the first time in American history Medicare is negotiating with the pharmaceutical industry to lower some of the most expensive prescription drug prices in America.

I am also proud of the accomplishments the Senate Committee on Health, Education, Labor, and Pensions (HELP), which I chair, has made to bring down the cost of prescription drugs.

Months ago, the HELP Committee launched an investigation into the outrageously high price of inhalers that 25 million Americans with asthma and 16 million Americans with chronic obstructive pulmonary disease (COPD) need to breathe.

After talking to the CEOs of the 4 major inhaler manufacturers, three of them have made a commitment to cap the cost of all of their brand name inhalers — Boehringer Ingelheim, AstraZeneca, and GlaxoSmithKline — to $35 at the counter, a substantial reduction in price. Up to this point Tevla has refused to join its competitors and lower its prices.

Last year, the CEO of Moderna committed during a HELP Committee hearing that his company would set up a patient assistance program so that no one in America would have to pay for their vaccine out of pocket.

In a separate HELP Committee hearing last May, the CEO of Eli Lilly committed that his company would not raise prices on existing insulin products after announcing very substantial price cuts for these products.

These efforts will improve life for millions of Americans. They will prevent unnecessary deaths, ease suffering, and save substantial sums of money for working class families.

But, despite all that we’ve accomplished, it is not enough. Not even close. Much more has to be done.

First, it is not just seniors who should be paying no more than $2,000 a year for prescription drugs — that must be made universal and extend to ALL Americans. Period. No matter what their health condition or how many prescription drugs they use, no one should pay more than $2,000 a year out-of-pocket.

There are also individual drugs like Ozempic, made by Novo Nordisk, that have the potential to be game changers in the diabetes and obesity epidemics. Yet, Americans are being charged outrageous and unsustainable prices for these products. We pay about $1,000 a month for this drug while the same exact product can be purchased for just $155 a month in Canada and just $59 in Germany. That may make sense to somebody, but not to me.

If we do not substantially reduce the price of this drug, millions who need it will be unable to afford it. Further, this extremely high price has the potential to bankrupt Medicare, the American people, and our entire healthcare system.

Further, we can no longer tolerate Astellas and Pfizer charging Americans with prostate cancer over $165,000 for Xtandi when that exact same product can be purchased for just $20,000 in Japan.

But it is not just these drugs — it is often the case that Americans are paying far more than people in other countries for the same exact medicines.

All over this country, the American people are asking why it is that they pay, by far, the highest prices in the world for prescription drugs?

The answer is simple. It is because drug companies in America are allowed to charge whatever they want. And that’s what they do. Their business model is not about how they can save and improve the lives of as many people as possible — it is about maximizing profit. And that is something that should offend everyone.

I have introduced legislation to cut the price of prescription drugs by at least 50% by preventing the pharmaceutical industry from charging more for medicine in the U.S. than they do in Canada, Britain, Germany, France, and Japan — a concept that is not only supported by progressives, but former President Donald Trump.

I have also introduced legislation to allow patients, pharmacists, and wholesalers to purchase affordable prescription drugs from Canada, the United Kingdom, and other major countries with strong safety standards.

I will soon be introducing legislation that would greatly expand Medicare’s ability to negotiate the price of prescription drugs.

Working together, we can take on the greed of the pharmaceutical industry and substantially lower the price of prescription drugs in America.

Yes. There are many issues which divide the American people — but not this one. Whether you are a Democrat, Republican, or Independent, a progressive or conservative, you understand that the extraordinary greed of the pharmaceutical industry must be ended.

When we do that, we will be improving the quality of life for millions of Americans while lowering the cost of healthcare in this country which is at least double that of any other wealthy country.

Let’s do it.

Bernie Sanders

[kepress]

Moderna inc

Moderna Inc. has paused construction of its messenger RNA product manufacturing plant in Kenya while it assesses future demand for its coronavirus vaccine in Africa. Moderna said in a statement Thursday that demand for coronavirus vaccines on the African continent has declined since the pandemic and is not enough to sustain a $500 million factory it plans to build in Kenya. As of 10:16 a.m. in New York, the stock was down 1.7%.

Source: Bloomberg

#news #moderna #kenya #africa #vaccine #covid 19

[vbadabeep]

[stlsystembuster]

KEY POINTS

Judge Thomas M. Rose of the U.S. District Court for the Southern District of Ohio has withdrawn from a case that could block Medicare’s historic drug price negotiation program.

Rose disclosed that he owned stock in AstraZeneca, Johnson & Johnson and Moderna.

J&J’s blood thinner Xarelto and AstraZeneca’s Type 2 diabetes drug Farxiga are among the 10 drugs subject to negotiations.

The U.S. Chamber of Commerce had asked Rose to block the drug negotiations before Oct. 1.

The case will be randomly reassigned to another judge in the district.

https://www.cnbc.com/2023/09/01/judge-withdraws-from-medicare-drug-price-case-after-stock-ownership-is-revealed.html

#big pharma #conflict of interest #us district court

[liu-lang]

hello i'm still alive, still recuperating.

i started to having a sore throat on sunday, july 10. this was how my covid during the december 2021 omicron wave started too. but since i already had covid, i didn't think anything of it.

i kept going to work like normal, eating cough drops. i got a pcr and rapid test from a tent outside work on monday, july 11 and it came back negative, i felt relieved. okay, maybe this is just a bad sore throat. by tuesday, july 12 i had a runny nose.

i woke up with chest pain that progressively got worse on wednesday, july 13. i also always have intermittent chest pain (like my whole life) so i didn't think much of it. i start to develop a cough on this day too. after work, i get another pcr and rapid test at a tent. i decide to go to urgent care for chest pain so i walk like 15 minutes to a citymd. by the time i get to citymd, i have my rapid test results, it says negative. i go in and explain my symptoms, i show the medical assistant my negative covid results from the tent test i took not even 1 hour ago. he seems chill about it, gives me a covid test just because and says he will do the strep test after.

(i get the PCR tent test from july 13 back the next day and that one comes back positive)

after 15 minutes he comes back and looks at my covid test and says "oh no you're positive" and he promptly leaves the appointment room and says a doctor will come see me. i am like super confused at this point but also this is familiar to me since this is exactly how my omicron covid diagnosis happened where my test at pharmacy/tents were all negative and i only got positive tests at urgent care.

the doctor comes in, he asks about my symptoms, when was the onset, what vaccines i have (all 3 moderna) and my prior medical history. i talk about my congential heart defects and he says he will give me paxlovid since i'm high risk and he implores me to make an appointment with a cardiologist. he tells me to watch for worsening symptoms especially fever or shortness of breath.

then the real nightmare begins. at this point, i am in midtown manhattan. i tell them to send the rx to the rite aid by my jackson heights apt since it's really close and all i wanna do is take the meds and sleep. i take the 7 train back home. i walk to the rite aid and they say they don't carry paxlovid. i'm confused. the pharmacist calls like 3 other rite aids in the area. no paxlovid - why no paxlovid in a densely populated neighbourhood with low income working class immigrants ?? the only other rite aid i can think of is the one by my ridgewood apartment. so i tell them to call and ofc they have it there. so then i have to go all the way back to ridgewood - i had to take 3 trains. i fetch the paxlovid and then i commute back to jackson heights. by this time, it's like after 20h - it literally took me over 5 hours to get the medicine i need. apparently you can search at pharmacy's websites to see what medicines they have in stock but the last stock date was 2 or 3 days before so who knows if they still had the medicine by then. how does this work ?

anyway, i didn't want to take chances and i had to do stuff at my old ridgewood apartment anyway. i take the paxlovid and am confused by the bitter metallic taste in my mouth. i learn about paxlovid mouth for the first time. it's major yucks but i'm still super grateful to have access to it even though i nearly passed out commuting to get this medicine.

i've been quarantining at home by myself. we have overlapping leases btwn the ridgewood place and this jackson heights place so the moment i texted my roommate i tested positive, she went to the ridgewood place. i haven't seen her in 5 days. CDC says 5 days quarantine but my job wants 10 days and a negative PCR test for my entry pass to be activated again and i can return. i have two at home covid test, i wonder if i should test a little before the 10 days or just wait. i think the paxlovid stopped my symptoms from progressing to something worse but it doesn't feel like it shortened the duration of my symptoms. omicron covid gave me really painful body aches and fever - this time i don't have either of those but my throat feels like i'm swallowing glass, i have a gross-sounding cough, nasal congestion and migraines. i have a high tolerance for heat (grew up in sg at the equator) but it doesn't help to live in a 5th floor walk up in the middle of summer with no ac. i think that contributed to my migranes. i haven't put up curtains in my room so once the sun's up my room would get unrelenting direct sunlight and i felt like i was being boiled alive. i'm also extremely fatigued. every time i got up to walk down the hallway, it felt like i was a hot air balloon that had been shot down and was slowly deflating and descending from the sky. my heartrate is consistently over 100 with the highest being like 130.

anyway can't believe i'm only half way through quarantine - i haven't seen anyone else in a week. i wake up and it takes me awhile to rmbr what day it is. i feel like my brain fog is very bad - this doesn't bode well for all the reading/learning i meant to do over the summer to prepare for year 2 of grad school.

on the plus side this is the last day of taking paxlovid - it’s been so disgusting tt I’ve barely been able to eat anything without instinctively retching right after. I did see this article where someone claimed cinnamon candy helped them - it’s too late for me but maybe someone else might find this helpful

#personal #nyc move #grad school #covid19

[news-of-the-day]

6/14/22

Russia is making gains in Severodonetsk and it's entered into street fighting.

Stocks are continuing to slide.

There is a convention of about 10K Southern Baptists in California right now to elect a new president as well as address a scandal of sexual abuse.  Last May a report was released that showed a decades-long massive coverup of hundreds of church leaders who sexually abused or assaulted members and would secretly move them to another congregation.

Congress passed a bill to protect Supreme Court Justice's families. Although this bill was in the works for over a month, it sped up after a man named Nicholas Rocke was arrested near Justice Kavanaugh's house last week with a gun. He called authorities on himself before he did anything, and said he was upset about the possible overturn of Roe v. Wade.

The FDA is recommending the Moderna vaccine for kids ages 6 to 17, but the Pfizer one has been available for a long time so it doesn't really matter at this point.

Since the news is slow today, I would like to discuss something that happened last week: the recall election of Chesa Boudin. Boudin was San Francisco's district attorney and came in on very progressive policies. Over time there was backlash as retail store owners complained of rampant stealing since people knew there wouldn't be prosecution; because of a proposition in 2014, theft under $950 is a misdemeanor and rarely prosecuted. Considering Boudin was elected in 2019 he's not responsible for that, but there were other complaints like lack of prosecution for drug dealing even after hundreds died of fentanyl. Overall it created a general sense of lawlessness amongst the populace. Many news media are focusing on this as a possible bellwether for the midterm elections: Because of progressive criminal reforms, Democrats are seen as soft on crime, and considering homicide went up by 30% in the past two years, Boudin's recall in very, very liberal San Francisco could be the first of many in the upcoming months.

1 Reuters 2 Bloomberg 3 Washington Post 4 NYT, The Hill 5 Politico 6 Atlantic, NYT, WSJ

How is this for the endnote style? Is it preferable to what I did before?

#news #war in ukraine #criminal reform #southern baptist church #brett kavanaugh

[bazaarbite]

What are some high return stocks?

Investing in individual stocks can potentially lead to high returns, but it's important to remember that it also comes with higher risk compared to diversified investments like index funds or ETFs. High return stocks often belong to companies with strong growth potential, innovative products or services, solid financials, and a competitive edge in their industry. However, these stocks can be volatile and may experience significant price fluctuations.

Here are some types of stocks that investors often consider for their potential for high returns:

Technology Stocks: Companies in the technology sector can offer high growth potential, especially those involved in areas like cloud computing, artificial intelligence, e-commerce, and software-as-a-service (SaaS). Examples include Apple Inc. (AAPL), Amazon.com Inc. (AMZN), Alphabet Inc. (GOOGL), and Microsoft Corporation (MSFT).

Biotech and Pharmaceutical Stocks: Biotechnology and pharmaceutical companies can see significant stock price movements based on the success of drug trials, FDA approvals, and breakthrough treatments. Examples include Moderna Inc. (MRNA), Pfizer Inc. (PFE), Biogen Inc. (BIIB), and Vertex Pharmaceuticals Incorporated (VRTX).

Consumer Discretionary Stocks: Companies that provide non-essential goods and services may experience strong growth during periods of economic expansion. This sector includes companies in retail, entertainment, travel, and luxury goods. Examples include Tesla Inc. (TSLA), Netflix Inc. (NFLX), Nike Inc. (NKE), and Starbucks Corporation (SBUX).

Renewable Energy Stocks: With increasing awareness of climate change and sustainability, companies involved in renewable energy, such as solar, wind, and electric vehicles, are gaining attention. Examples include Tesla Inc. (TSLA), NextEra Energy Inc. (NEE), Enphase Energy Inc. (ENPH), and Plug Power Inc. (PLUG).

Growth Stocks: These are companies that are expected to grow at an above-average rate compared to other companies in the market. Growth stocks may not always pay dividends but reinvest earnings to fuel further growth. Examples include Zoom Video Communications Inc. (ZM), Square Inc. (SQ), Shopify Inc. (SHOP), and Peloton Interactive Inc. (PTON).

While these stocks have the potential for high returns, it's crucial to conduct thorough research, consider your risk tolerance, and diversify your investments to mitigate risk. Additionally, past performance is not indicative of future results, so it's essential to invest with a long-term perspective. If you're uncertain, consider consulting a financial advisor before making investment decisions.

LTP Calculator Overview:                 

LTP Calculator is a comprehensive stock market trading tool that focuses on providing real-time data, particularly the last traded price of various stocks. Its functionality extends beyond a conventional calculator, offering insights and analytics crucial for traders navigating the complexities of the stock market.

Also Available on Play store  -  Get the App

Key Features:

Real-time Last Traded Price:

The core feature of LTP Calculator is its ability to provide users with the latest information on stock prices. This real-time data empowers traders to make timely decisions based on the most recent market movements.

User-Friendly Interface:

Designed with traders in mind, LTP Calculator boasts a user-friendly interface that simplifies complex market data. This accessibility ensures that both novice and experienced traders can leverage the tool effectively.

Analytical Tools:

Beyond basic price information, LTP Calculator incorporates analytical tools that help users assess market trends, volatility, and potential risks. This multifaceted approach enables traders to develop a comprehensive understanding of the stocks they are dealing with.

Customizable Alerts:

Recognizing the importance of staying informed, LTP Calculator allows users to set customizable alerts for specific stocks. This feature ensures that traders receive timely notifications about significant market movements affecting their portfolio.

Vinay Prakash Tiwari - The Visionary Founder:

At the helm of LTP Calculator is Vinay Prakash Tiwari, a renowned figure in the stock market training arena. With a moniker like "Investment Daddy," Tiwari has earned respect for his expertise and commitment to empowering individuals in the financial domain.

Professional Background:

Vinay Prakash Tiwari brings a wealth of experience to the table, having traversed the intricacies of the stock market for several decades. His journey as a stock market trainer has equipped him with insights into the challenges faced by traders, inspiring him to develop tools like LTP Calculator.

Philosophy and Approach:

Tiwari's approach to stock market training revolves around education, empowerment, and simplifying complexities. LTP Calculator reflects this philosophy, offering a tool that aligns with his vision of making stock market information accessible and understandable for all.

Educational Initiatives:

Apart from his contributions as a tool developer, Vinay Prakash Tiwari has actively engaged in educational initiatives. Through online courses, webinars, and seminars, he has shared his knowledge with aspiring traders, reinforcing his commitment to fostering financial literacy.

In conclusion, LTP Calculator stands as a testament to Vinay Prakash Tiwari's dedication to enhancing the trading experience. As the financial landscape continues to evolve, tools like LTP Calculator and visionaries like Tiwari sir play a pivotal role in shaping a more informed and empowered community of traders.

#ltp calculator #calculator #ltp

[decentralvaccine]

Board Shakeup At Novavax

A top-five shareholder in struggling Covid-19 vaccine maker Novavax is calling for an “urgent shake-up” of the board and an overhaul of its sales strategy, as the stock is down 99 per cent from its pandemic peak.

US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors. It also wants a pivot in the biotech’s sales strategy for its Covid-19 shot, which is based on traditional vaccine technology, to target older people unnerved by rare side effects associated with mRNA jabs from Pfizer and Moderna.

https://www.ft.com/content/7d731522-26c6-4c60-a528-d52f4d89cd5a

[reality-detective]

Just to let you know things ARE happening behind the scenes, I'll leave this here 👇

Operation Warp Speed Architect Arrested

U.S. Army Rangers on Saturday arrested Operation Warp Speed architect Moncef Slaoui, the Moroccan-born pharmaceutical mogul who in May 2020 spearheaded the administration’s efforts to poison 300 million Americans by January 2021, a source in General Eric M. Smith’s said.

Slaoui largely flew under the radar throughout the Plandemic. The media seldom mentioned his name, focusing instead on publicly influential figures like Fauci, Birx, and Collins, articulate public servants who spoke better English. Our source said Slaoui was relegated to media obscurity because the administration thought he looked shady and that Americans wouldn’t trust him.

And Americans would have been right not to trust a man who spent 30 years as GlaxoSmithKline’s head of vaccines department and was working at Moderna when Trump picked him to helm Warp Speed. At the time, Trump called Slaoui “one of the most respected men in the world in the production and, really, on the formulation of vaccines,” but was merely parroting what subordinates Michael Pence, Alex Azar, Admiral Brett Giroir, and Robert Redfield told him. They and others, our source said, were part of a major conspiracy to deceive President Trump into putting Slaoui in charge of OWS.

Slaoui faced criticism for holding $10 million in Moderna stock options and working as an advisor to Brii Biosciences, a firm with sizable Chinese investments. To avoid a conflict of interest, he begrudgingly resigned from those positions, then began working with then-Health and Human Services Secretary Alex Azar—who praised Slaoui as “arguably the world’s most experienced and successful vaccine developer”—to hasten Warp Speed.

Our source said that Slaoui, despite resigning from Moderna, continued receiving payouts exceeding $56 million after the FDA granted Moderna emergency-use authorization on December 8, 2020.

However, the military was less interested in Slaoui’s financial motivations than his knowledge that Moderna’s experimental vaccine had killed 34 of 600 Phase II trial participants in June 2020. White Hats, our source said, now have a wealth of evidence—physical and digital documents authored by Slaoui—proving he knew the vaccine caused myocarditis and potentially lethal blood clots but never publicly disclosed that information, even after Trump personally asked him if the shots were truly safe and effective.

“We have a treasure chest of incriminating evidence on Slaoui. This guy was one of the biggest violators of the Plandemic. We got a letter he wrote to Pence, saying he knew vaccines would kill people and that they could blame Trump for pushing Operation Warp Speed on the public. We have tons more that will be made available when he faces a military tribunal and hopefully gets hanged. We had more than enough proof to get him,” our source said.

The arrest, he added, came after Gen. Smith talked with Colonel J.D. Keirsey, a White Hat council member and commander of the 75th Ranger Regiment, the U.S. Army’s premier light infantry unit and special operations force within the United States Army Special Operations Command.

On Saturday morning, Rangers bashed down the door to Slaoui’s 7,500-sq-ft home in Zebulon, North Carolina. One of his three sons, Hussein Mohamad Abdul Slaoui, was present and pulled a pistol on the Rangers. He was shot dead, and the Rangers took Slaoui into custody. He shouted, “sayantaqim li allah,” or “Allah will avenge me,” as the Rangers shoved him into a civilian vehicle.

“We got him. We got the bastard,” our source said. “He’s just one of many. But we’re chipping away at them.”

As an aside, Slaoui was fired from chairman of the board of directors of Galvani Bioelectronics, a subsidiary of GlaxoSmithKline, in March 2021 after several young male employees accused him of sexual harassment.

#pay attention #educate yourself #educate yourselves #reeducate yourself #knowledge is power #reeducate yourselves #think for yourself #think for yourselves #think about it #do your homework #do your research #do your own research #question everything #ask yourself questions #ask yourself #truthful news #real news #world news #news #not in the news #you decide

[reddancer1]

why Big Pharma is criminal

The National Institute of Health (NIH) is responsible for the development of many important drugs. Yet, despite that taxpayer support, the major drug companies make billions as they charge us the highest prices in the world for their products. Enough is enough. We must hold the pharmaceutical industry accountable.

I hope you’ll take a minute to read an op-ed I wrote today for FOX News.

OPINION · Published January 23, 2023 2:00am EST

Greedy pharma firms rip off Americans while Pfizer, Moderna swim in profits

5 of the largest US pharma firms totaled $80 billion in profits, but millions of Americans can’t afford medicine

By Sen. Bernie Sanders

There is a lot of discussion about how "divided" our nation is and, on many issues, that is absolutely true. But on one of the most important matters facing our country the American people – Democrats, Republicans, Independents, Progressives, Conservatives – could not be more united. And that is the need to take on the unprecedented corporate greed of the pharmaceutical industry and to substantially lower the outrageously high price of prescription drugs.

Today, millions of Americans are making the unacceptable choice between feeding their families or buying the medicine they need. Seniors from Vermont to Alaska are forced to split pills in half and many have died because they did not have enough money to fill their prescriptions.

All over this country, the American people are asking why it is that they pay, by far, the highest prices in the world for prescription drugs?

Why is it that nearly one out of every four adults in America cannot afford their prescription medication?

Why do nearly half of all new drugs in the United States cost more than $150,000 a year?

Several years ago, I took a busload of people with diabetes from Detroit, Michigan, to a drugstore in Windsor, Ontario. There, they were able to purchase the same insulin products they bought in the United States for one-tenth the price.

How is it that in Canada and other major countries the same medications manufactured by the same companies, sold in the same bottles are available for a fraction of the price that we pay in the United States?

The answers can be summed up in three words: Follow the money.

Over the past 25 years, the pharmaceutical industry has spent $8.5 billion on lobbying and over $745 million on campaign contributions to buy politicians. Incredibly, last year, the drug companies hired over 1,700 lobbyists including the former congressional leaders of both major political parties – over 3 pharmaceutical industry lobbyists for every Member of Congress.

The situation has become so absurd that Pfizer donated a million dollars to the Republican Party in Kentucky to expand its headquarters named after Senator Mitch McConnell, after Pfizer increased its profits by 140% in 2021 to $22 billion.

Meanwhile, as Americans die because they cannot afford the medications they need, five of the largest drug companies in the U.S. made nearly $80 billion in profits last year (a 104% increase from the previous year) while the CEOs of just 13 pharmaceutical companies made over $1 billion in total compensation in 2021.

Over the past decade, 14 major pharmaceutical companies spent $747 billion not to make life-saving drugs more affordable, but to make their wealthy shareholders richer by buying back their own stock and handing out huge dividends – a sum that is $87 billion more than what they spent on research and development.

Examples of corporate greed within the pharmaceutical industry are limitless. Let's start with Moderna. This is a company that received $1.7 billion from U.S. taxpayers to research and develop the COVID-19 vaccine and billions more to distribute it to the American people. As a result, Moderna made $19 billion in profits over the past two years and its CEO (Stéphane Bancel) became a billionaire who is now worth over $6 billion. What is Moderna doing to thank the American taxpayer for their generous support? It plans to raise the price of the COVID-19 vaccine by 400% up to $130 when it goes on the commercial market. Meanwhile, it costs just $2.85 to manufacture the product. And, by the way, Moderna has already approved a $926 million golden parachute for Mr. Bancel once he leaves the company.

Moderna is far from alone. A number of years ago, the former CEO of Gilead became a billionaire by charging $1,000 for Sovaldi, a hepatitis C drug that was discovered by scientists at the Veterans Administration, costs just $1 to manufacture, and could be purchased in India for $4.

The Japanese drugmaker Astellas, which made a billion dollars in profits in 2021, recently raised the price of the prostate cancer drug Xtandi by more than 75% in the United States to nearly $190,000. This is a drug that was invented by federally funded scientists at UCLA and can be purchased in Canada for one-sixth the US price.

Last year over 1 million Americans with diabetes had to ration insulin because they could not afford to take it as prescribed. Why? In large part because Eli Lilly, which made $5.6 billion in profits in 2021, increased the price of Humalog by 1200% since 1996 to $275 while its CEO made nearly $50 million in compensation making him one of the highest-paid pharmaceutical CEOs in America. Humalog costs an estimated $8 to produce and can be purchased for about one-tenth the price in Canada.

It does not have to be this way. The reality is that if Congress had the courage to take on the greed of the pharmaceutical industry, we could cut the price of prescription drugs in America by at least 50%. How? By preventing the pharmaceutical industry from charging more for prescription drugs in the U.S. than they do in Canada, Britain, Germany, France and Japan – a concept that is not only supported by progressives, but former President Donald Trump. I will soon be re-introducing legislation in the Senate to do just that.

There is no rational reason why the HIV treatment Biktarvy costs $45,540 per year in the U.S but only $7,500 per year in France. Or why a weekly dose of the autoimmune medicine Enbrel costs $1,762 in the U.S. but just $300 in Canada. Or why a vial of insulin costs $98.70 in the U.S., but just $11 in Germany.

A life-saving drug is not effective if a person who needs that drug cannot afford it. How many more Americans must die before Congress finally has the guts to stop the pharmaceutical industry from getting away with murder?